Vibeke Strand, MD is an adjunct clinical professor in the Division of Immunology and Rheumatology at Stanford University School of Medicine since 1993, previously at UCSF. Since 1991, she has led a consulting practice offering clinical research and regulatory strategy expertise to pharmaceutical / biotech companies for development of new therapies in rheumatology.

She participated in the development of all approved b- and ts-DMARDs in RA, and new therapies for SLE, PsA, SpA, vasculitis, gout, biosimilars and OA.

She has authored >550 publications, is a Fellow of the American College of Physicians (1982), Master of the American College of Rheumatology (2015) and member of the Cosmos Club (1994). She has been a member of the Executive Committee of OMERACT consensus conferences since its inception in 1992–; Steering Committee of Group for Research and Assessment of PsO and PsA [GRAPPA] (2003–) and Board of International Dermatology Outcome Measures [IDEOM] (2019–). She serves on the Medical and Scientific Committee of Northern California Chapter of the Arthritis Foundation (2005–)